World Schizophrenia Day

#Schizophrenia is a psychiatric diagnosis characterized by continuous or recurrent episodes of psychosis. This is one of the most complex and serious mental health disorders that can be inherited. In the general population, only one percent of people develop it during their lifetime.

It is an interesting fact that the term ‘schizophrenia’ literally means “a splitting of the mind”.

Signs and symptoms of schizophrenia include:

  • Delusions
  • Hallucinations
  • Disorganized thinking and speech
  • Extremely disorganized or abnormal motor behavior
  • Disturbances of emotions
  • Reduced or lack of ability to function normally

Schizophrenia is treated with a combination of medication, psychological care, and community support, however, that differs between the countries.

GCT has extensive experience in psychiatry research and schizophrenia in particular. Various pharmaceutical companies entrust GCT to conduct these studies and connect them with local KOLs. Contact to find out more about our CNS experience.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.